Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Tuesday, August 16, 2011
Use of New HCV Protease Inhibitors ‘Not That Simple’
Within two weeks, more than 115 patients had phoned the office asking about the much-anticipated, direct-acting antivirals. Patients wanted to know if they were candidates for one of the new agents and if they could trade their pegylated interferon and ribavirin regimen for one of the new therapies. And, most often, they wanted to know when they could start.